Adriana Costal, MSc
Genetic Counselor
IDIBELL node
Barbara Rivera, PhD
Principal Investigator of the IDIBELL node
Carla Roca, MSc
PhD student
IDIBELL node
Cristina Rioja, PhD
Biobank and lab manager
IDIBELL node
Conxi Lazaro, PhD
Chief of clinical and molecular diagnostics
IDIBELL node
Juana Fernandez-Rodriguez, PhD
Chief of the Mouse Lab
IDIBELL node
Silvia Iglesias
Genetic Counselor
IDIBELL node
The IDIBELL is a research center in biomedicine focused in cancer, neuroscience, translational medicine and regenerative medicine.
It is promoted by the Bellvitge University Hospital and the Viladecans Hospital, both from the Catalan Health Institute, the Catalan Institute of Oncology, University of Barcelona and L’Hospitalet de Llobregat city council.
The Institute of Health Carlos III is a national and international reference in biomedical research and public health in Spain. It is the Public Research Organization of the Government responsible for funding and executing national biomedical research. It depends on the Ministry of Science, Innovation and Universities.
This funding program awarded our initiative to further develop our Registry and integrate it into an international Network for Rare Tumors of the Ovary (NRTO). The SCSTs Registry & Biobank is part of this network. * Inclusion on this web page does not constitute expressed or implied endorsement by the Department of the Army, Department of Defense, or the U.S. government.*
Contact.
Head office
Rare Tumors Lab – Hereditary Cancer Programme Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Avinguda de la Granvia de l’Hospitalet, 199, 08908 L’Hospitalet de Llobregat, Barcelona, Spain
Contact information
Phone: (+34) 93 607 38 00 Ext. 7128
Email address: ovarianscsts@idibell.cat
